Clinical trial
Epirubicin and Cyclophosphamide Compared With Epirubicin and Paclitaxel in…
NCT00002953 · Medical Research Council, Other · Completed
Key facts
| NCT number | NCT00002953 |
|---|---|
| Title | Epirubicin and Cyclophosphamide Compared With Epirubicin and Paclitaxel in Treating Women With Metastatic Breast Cancer |
| Official title | A Radomized Trial of Epirubicin & Cyclophosphamide vs. Epirubicin & Paclitaxel in the Treatment of Women With Metastatic Breast Cancer |
| Lead sponsor | Medical Research Council, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | cyclophosphamide, epirubicin hydrochloride, paclitaxel |
| Enrollment | 704 |
| Start date | Dec 1, 1996 |
| Completion | Nov 1, 2005 |
| First posted | Jul 7, 2004 |
| Last update posted | Dec 4, 2013 |
| Countries | South Africa, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: